BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35124828)

  • 1. Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018.
    Alvarez CS; Petrick JL; Parisi D; McMahon BJ; Graubard BI; McGlynn KA
    Hepatology; 2022 Sep; 76(3):589-598. PubMed ID: 35124828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State-Level HCC Incidence and Association With Obesity and Physical Activity in the United States.
    Lee YT; Wang JJ; Luu M; Tseng HR; Rich NE; Lu SC; Nissen NN; Noureddin M; Singal AG; Yang JD
    Hepatology; 2021 Sep; 74(3):1384-1394. PubMed ID: 33728665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing incidence of hepatocellular carcinoma among most racial groups: SEER-22, 2000-2019.
    O'Brien TR; Devesa SS; Koshiol J; Marrero JA; Shiels MS
    Cancer Med; 2023 Oct; 12(19):19960-19967. PubMed ID: 37776201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
    Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.
    Altekruse SF; McGlynn KA; Reichman ME
    J Clin Oncol; 2009 Mar; 27(9):1485-91. PubMed ID: 19224838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
    Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
    Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.
    Ryerson AB; Eheman CR; Altekruse SF; Ward JW; Jemal A; Sherman RL; Henley SJ; Holtzman D; Lake A; Noone AM; Anderson RN; Ma J; Ly KN; Cronin KA; Penberthy L; Kohler BA
    Cancer; 2016 May; 122(9):1312-37. PubMed ID: 26959385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.
    Yang B; Liu JB; So SK; Han SS; Wang SS; Hertz A; Shariff-Marco S; Lin Gomez S; Rosenberg PS; Nguyen MH; Hsing AW
    Cancer; 2018 Sep; 124(17):3551-3559. PubMed ID: 30113700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis.
    Zhang X; El-Serag HB; Thrift AP
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):88-94. PubMed ID: 31712271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
    Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
    Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data.
    Shiels MS; Chernyavskiy P; Anderson WF; Best AF; Haozous EA; Hartge P; Rosenberg PS; Thomas D; Freedman ND; Berrington de Gonzalez A
    Lancet; 2017 Mar; 389(10073):1043-1054. PubMed ID: 28131493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.
    Rich NE; Yopp AC; Singal AG; Murphy CC
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in hepatocellular carcinoma stage by racial/ethnic group in the United States, 1992-2019.
    Alvarez CS; Ruhl J; Flynn G; Graubard BI; McGlynn KA
    JHEP Rep; 2023 Nov; 5(11):100868. PubMed ID: 37799980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial and Ethnic Disparities in Alcohol-Attributed Deaths in the United States, 1999-2020.
    Karaye IM; Maleki N; Yunusa I
    Int J Environ Res Public Health; 2023 Apr; 20(8):. PubMed ID: 37107870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changing trends in liver cancer incidence by race/ethnicity and sex in the US: 1992-2016.
    Salvatore M; Jeon J; Meza R
    Cancer Causes Control; 2019 Dec; 30(12):1377-1388. PubMed ID: 31606852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States.
    Artinyan A; Mailey B; Sanchez-Luege N; Khalili J; Sun CL; Bhatia S; Wagman LD; Nissen N; Colquhoun SD; Kim J
    Cancer; 2010 Mar; 116(5):1367-77. PubMed ID: 20101732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striking Racial/Ethnic Disparities in Liver Cancer Incidence Rates and Temporal Trends in California, 1988-2012.
    Pham C; Fong TL; Zhang J; Liu L
    J Natl Cancer Inst; 2018 Nov; 110(11):1259-1269. PubMed ID: 29617913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.
    Kim D; Li AA; Perumpail BJ; Gadiparthi C; Kim W; Cholankeril G; Glenn JS; Harrison SA; Younossi ZM; Ahmed A
    Hepatology; 2019 Mar; 69(3):1064-1074. PubMed ID: 30014489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in Hepatocellular Carcinoma Incidence in California: An Update.
    Sangaramoorthy M; Yang J; DeRouen MC; Ho C; Somsouk M; Tana MM; Thompson CA; Gibbons J; Gomez SL; Shariff-Marco S
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):79-87. PubMed ID: 31719066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.